Litigation Involving Intravitreal Injections in Ophthalmology
- 10 October 2025
- journal article
- Published by Elsevier in Ophthalmology Retina
- Vol. 10 (3) , 283-293
Abstract
No abstract availableKeywords
Funding Information
- VitreoRetinal Surgery Foundation
This publication has 32 references indexed in Scilit:
- Canadian legal cases in ophthalmology: a closer look at 40 years’ worth of dataCanadian Journal of Ophthalmology, 2023
- Malpractice Litigation in GlaucomaOphthalmology Glaucoma, 2021
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular DegenerationOphthalmology, 2020
- Analysis of Anti–Vascular Endothelial Growth Factor Injection Claims Data in US Medicare Part B Beneficiaries From 2012 to 2015JAMA Ophthalmology, 2019
- Implementation of Bar-Code Medication Administration to Reduce Patient HarmMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2018
- Rates and Characteristics of Paid Malpractice Claims Among US Physicians by Specialty, 1992-2014JAMA Internal Medicine, 2017
- Malpractice Litigation in Pediatric OphthalmologyJAMA Ophthalmology, 2016
- A Brief History of Anti-VEGF for the Treatment of Ocular AngiogenesisThe American Journal of Pathology, 2012
- Outcomes of Medical Malpractice Litigation Against US PhysiciansArchives of internal medicine (1960), 2012
- Defensive Medicine Among High-Risk Specialist Physicians in a Volatile Malpractice EnvironmentJAMA, 2005